title: Half-life and safety of canakinumab in pediatric patients: comment on the article by Ilowite et Al.
authors.affiliation: Cincinnati Children's Hospital Medical Center, Cincinnati, OH.
authors.forename: Hermine
authors.initials: H
authors.lastname: Brunner
authors.forename: Kathleen Graham
authors.initials: KG
authors.lastname: Lomax
authors.forename: Stephane
authors.initials: S
authors.lastname: Levy
mesh_terms: D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001171:Arthritis, Juvenile / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D011993:Recombinant Fusion Proteins / Q000627:therapeutic use*
chemical_list: D018501:Antirheumatic Agents; D011993:Recombinant Fusion Proteins